Vasopressin compared with norepinephrine augments the decline of plasma cytokine levels in septic shock.

TitleVasopressin compared with norepinephrine augments the decline of plasma cytokine levels in septic shock.
Publication TypeJournal Article
Year of Publication2013
AuthorsRussell, JA, Fjell, C, Hsu, JL, Lee, T, Boyd, J, Thair, S, Singer, J, Patterson, AJ, Walley, KR
JournalAm J Respir Crit Care Med
Date Published2013 Aug 1
KeywordsAdolescent, Adrenergic alpha-Agonists, Adult, Aged, Aged, 80 and over, Biological Markers, Cytokines, Disease Progression, Double-Blind Method, Female, Follow-Up Studies, Humans, Male, Middle Aged, Norepinephrine, Shock, Septic, Survival Rate, Treatment Outcome, United States, Vasoconstrictor Agents, Vasopressins, Young Adult

RATIONALE: Changes in plasma cytokine levels may predict mortality, and therapies (vasopressin versus norepinephrine) could change plasma cytokine levels in early septic shock.OBJECTIVES: Our hypotheses were that changes in plasma cytokine levels over 24 hours differ between survivors and nonsurvivors, and that there are different effects of vasopressin and norepinephrine on plasma cytokine levels in septic shock.METHODS: We studied 394 patients in a randomized, controlled trial of vasopressin versus norepinephrine in septic shock. We used hierarchical clustering and principal components analysis of the baseline cytokine concentrations to subgroup cytokines; we then compared survivors to nonsurvivors (28 d) and compared vasopressin- versus norepinephrine-induced changes in cytokine levels over 24 hours.MEASUREMENTS AND MAIN RESULTS: A total of 39 plasma cytokines were measured at baseline and at 24 hours. Hierarchical clustering and principal components analysis grouped cytokines similarly. Survivors (versus nonsurvivors) had greater decreases of overall cytokine levels (P < 0.001). Vasopressin decreased overall 24-hour cytokine concentration compared with norepinephrine (P = 0.037). In less severe septic shock, the difference in plasma cytokine reduction over 24 hours between survivors and nonsurvivors was less pronounced than that seen in more severe septic shock. Furthermore, vasopressin decreased interferon-inducible protein 10 and granulocyte colony-stimulating factor more than did norepinephrine in less severe septic shock, whereas vasopressin decreased granulocyte-macrophage colony-stimulating factor in patients who had more severe shock.CONCLUSIONS: Survivors of septic shock had greater decreases of cytokines, chemokines and growth factors in early septic shock. Vasopressin decreased 24-hour plasma cytokine levels more than did norepinephrine. The vasopressin-associated decrease of cytokines differed according to severity of shock. Clinical trial registered with (ISRCTN94845869).

Alternate JournalAm. J. Respir. Crit. Care Med.
PubMed ID23796235
Grant ListMCT 44152 / / Canadian Institutes of Health Research / Canada